75000 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 75010 - Statement - CONDENSED BALANCE SHEETS (Unaudited) link:presentationLink link:calculationLink link:definitionLink 75020 - Disclosure - Balance Sheet Components - Schedule of Accrued Expenses and Other Current Liabilities (Details) 2 link:presentationLink link:calculationLink link:definitionLink 75030 - Statement - CONDENSED BALANCE SHEETS (Parenthetical) (Unaudited) link:presentationLink link:calculationLink link:definitionLink 75040 - Statement - CONDENSED STATEMENTS OF CASH FLOWS (Unaudited) 2 link:presentationLink link:calculationLink link:definitionLink 75050 - Disclosure - Term Loan - Schedule of Future Principal Payments (Details) 3 link:presentationLink link:calculationLink link:definitionLink 75060 - Statement - CONDENSED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (Unaudited) link:presentationLink link:calculationLink link:definitionLink 75070 - Statement - CONDENSED STATEMENT OF STOCKHOLDERS' EQUITY (Unaudited) link:presentationLink link:calculationLink link:definitionLink 75080 - Statement - CONDENSED STATEMENT OF STOCKHOLDERS' EQUITY (Parenthetical) (Unaudited) link:presentationLink link:calculationLink link:definitionLink 75090 - Statement - CONDENSED STATEMENTS OF CASH FLOWS (Unaudited) link:presentationLink link:calculationLink link:definitionLink 995455 - Disclosure - Organization and Principal Activities link:presentationLink link:calculationLink link:definitionLink 995465 - Disclosure - Summary of Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 995475 - Disclosure - Fair Value Measurements link:presentationLink link:calculationLink link:definitionLink 995485 - Disclosure - Balance Sheet Components link:presentationLink link:calculationLink link:definitionLink 995495 - Disclosure - Leases link:presentationLink link:calculationLink link:definitionLink 995505 - Disclosure - Term Loan link:presentationLink link:calculationLink link:definitionLink 995515 - Disclosure - License and Purchase Agreements link:presentationLink link:calculationLink link:definitionLink 995525 - Disclosure - Commitments and Contingencies link:presentationLink link:calculationLink link:definitionLink 995535 - Disclosure - Capital Structure link:presentationLink link:calculationLink link:definitionLink 995545 - Disclosure - Stock-Based Compensation Expense link:presentationLink link:calculationLink link:definitionLink 995555 - Disclosure - Income Taxes link:presentationLink link:calculationLink link:definitionLink 995565 - Disclosure - Net Loss Per Share link:presentationLink link:calculationLink link:definitionLink 995575 - Disclosure - Related Party Transactions link:presentationLink link:calculationLink link:definitionLink 995585 - Disclosure - Subsequent Events link:presentationLink link:calculationLink link:definitionLink 995595 - Disclosure - Summary of Significant Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 995605 - Disclosure - Fair Value Measurements (Tables) link:presentationLink link:calculationLink link:definitionLink 995615 - Disclosure - Balance Sheet Components (Tables) link:presentationLink link:calculationLink link:definitionLink 995625 - Disclosure - Term Loan (Tables) link:presentationLink link:calculationLink link:definitionLink 995635 - Disclosure - Capital Structure (Tables) link:presentationLink link:calculationLink link:definitionLink 995645 - Disclosure - Stock-Based Compensation Expense (Tables) link:presentationLink link:calculationLink link:definitionLink 995655 - Disclosure - Net Loss Per Share (Tables) link:presentationLink link:calculationLink link:definitionLink 995665 - Disclosure - Organization and Principal Activities - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 995675 - Disclosure - Summary of Significant Accounting Policies (Additional Information) (Details) link:presentationLink link:calculationLink link:definitionLink 995685 - Disclosure - Fair Value Measurements - Summary of Financial Assets and Liabilities Measured at Fair Value on Recurring Basis (Details) link:presentationLink link:calculationLink link:definitionLink 995695 - Disclosure - Fair Value Measurements - Schedule of Pre-funded Warrants Measured Using Black-Scholes Option Pricing Model (Details) link:presentationLink link:calculationLink link:definitionLink 995705 - Disclosure - Fair Value Measurements - Schedule of Aggregate Fair Value of Warrant Liability (Details) link:presentationLink link:calculationLink link:definitionLink 995715 - Disclosure - Fair Value Measurements - Summary of Investments in an Unrealized Loss Position (Details) link:presentationLink link:calculationLink link:definitionLink 995725 - Disclosure - Fair Value Measurements - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 995735 - Disclosure - Balance Sheet Components - Schedule of Accrued Expenses and Other Current Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 995745 - Disclosure - Leases - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 995755 - Disclosure - Term Loan - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 995765 - Disclosure - Term Loan - Schedule of Future Principal Payments (Details) link:presentationLink link:calculationLink link:definitionLink 995775 - Disclosure - License and Purchase Agreements - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 995785 - Disclosure - Commitments and Contingencies - Additional Information (Detail) link:presentationLink link:calculationLink link:definitionLink 995795 - Disclosure - Capital Structure - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 995805 - Disclosure - Capital Structure - Summary of Common Stock Reserved for Future Issuance (Details) link:presentationLink link:calculationLink link:definitionLink 995815 - Disclosure - Stock-Based Compensation Expense - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 995825 - Disclosure - Stock-Based Compensation Expense - Summary of Stock-Based Compensation Expense (Details) link:presentationLink link:calculationLink link:definitionLink 995835 - Disclosure - Net Loss Per Share - Schedule of Computation of Basic and Diluted Net Loss Per Share (Details) link:presentationLink link:calculationLink link:definitionLink 995845 - Disclosure - Net Loss Per Share - Schedule of Potentially Dilutive Securities not Included in Calculation of Diluted Per Share (Details) link:presentationLink link:calculationLink link:definitionLink 995855 - Disclosure - Related Party Transactions - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 995865 - Disclosure - Subsequent Events Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Number, Beginning Balance Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Number, Ending Balance Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Number Number of RSUs outstanding Accrued compensation and benefits Accrued Employee Benefits, Current Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Preferred Stock, Shares Issued, Total Preferred stock, shares issued Preferred Stock, Shares Issued Increase (Decrease) in Accounts Payable, Total Increase (Decrease) in Accounts Payable Accounts payable Long-term Debt, Excluding Current Maturities, Total Term loan, net of current portion Long-Term Debt, Excluding Current Maturities Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer Fair value, twelve months or greater Equity [Abstract] Entity Current Reporting Status Entity Current Reporting Status Proceeds from Warrant Exercises Proceeds from exercise of pre-funded warrants US Government Agencies Debt Securities [Member] US government Agency Securities Operating expenses: Operating Expenses [Abstract] Level 2 Fair Value, Inputs, Level 2 [Member] Commitments and Contingencies Disclosure [Text Block] Commitments and Contingencies Common stock shares authorized Common stock, shares authorized Common Stock, Shares Authorized Eli Lilly and company. Eli Lilly and Company Eli Lilly And Company [Member] Reverse Stock Split [Member] Reverse Stock Split [Member] Reverse Stock Split Product and Service [Axis] Preferred Stock, Voting Rights Preferred stock, voting rights Short term lease additional commitments Short Term Lease Additional Commitments Short term lease additional commitments. Document Fiscal Period Focus Document Fiscal Period Focus Accrued Expenses and Other Current Liabilities Accrued expenses and other current liabilities. Accrued expenses and other current liabilities Debt Instrument, Interest Rate, Stated Percentage Interest rate of term loan Entity Shell Company Entity Shell Company Segment Reporting, Policy [Policy Text Block] Segment Reporting Cash and Cash Equivalents, at Carrying Value, Ending Balance Cash and Cash Equivalents, at Carrying Value, Beginning Balance Cash and Cash Equivalents, at Carrying Value, Total Cash and cash equivalents Cash and cash equivalents Cash and Cash Equivalent Denominator: Weighted Average Number of Shares Outstanding Reconciliation [Abstract] Schedule of Future Principal Payments Schedule of Maturities of Long-Term Debt [Table Text Block] Amount of amortization expense for right-of-use asset from leases. Amount of Amortization Expense for Right-Of-Use Asset From Leases Non-cash lease expense Research and Development Arrangement, Contract to Perform for Others, Type [Axis] Common Stock, Shares, Issued, Total Common stock, shares issued Common Stock, Shares, Issued Statement [Table] Statement [Table] Restricted cash Restricted Cash, Noncurrent Restricted cash, long-term (included in other assets) Number of shares issuable upon the exercise of warrant Number Of Shares Issuable Upon Exercise Of Warrants Number of shares issuable upon exercise of warrants. Consideration paid Payments to Acquire Businesses, Gross Statement [Line Items] Statement [Line Items] Warrant Warrant [Member] Standard Warrants Entity Filer Category Entity Filer Category Liabilities and Equity Total liabilities, redeemable preferred stock, and stockholders' equity Debt Instrument [Line Items] Debt Instrument [Line Items] Long-term Debt, Current Maturities, Total Less: Term Loan, current portion Term loan, current portion Long-Term Debt, Current Maturities 2026 Long-Term Debt, Maturity, Year Three Cash equivalents, fair value Cash and cash equivalents, fair value Cash and Cash Equivalents, Fair Value Disclosure Cash equivalents and available for sale securities, amortized cost Subsequent Event [Line Items] Organization And Principal Activities [Table] Organization And Principal Activities [Table] Organization and principal activities. Stock Options, Issued and Outstanding Research and Development Arrangement, Contract to Perform for Others, Description and Terms Research term Estimated fair value of the warrant Estimated Fair Value Of Warrant Estimated fair value of warrant. Geographical [Domain] Fair Value of Pre Funded Warrants Issued Fair value of pre-funded warrants issued. Fair value of pre-funded warrants issued Additional Paid in Capital, Common Stock, Ending Balance Additional Paid in Capital, Common Stock, Beginning Balance Additional paid-in capital Additional Paid in Capital, Common Stock Summary of Significant Accounting Policies Significant Accounting Policies [Text Block] Measurement Input, Risk Free Interest Rate [Member] Risk-free interest rate Vesting [Domain] Stock Options, Available for Future Issuance Stock Options Available For Future Issuance [Member] Stock options, available for future issuance. Schedule of Computation of Basic and Diluted Net Loss Per Share Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Probable of achievement member. Probable Of Achievement [Member] Probable of Achievement Recent Accounting Pronouncements - Not Yet Adopted Recent accounting pronouncements not yet adopted. Recent Accounting Pronouncements Not Yet Adopted Policy [Text Block] Net loss per share, basic Earnings Per Share, Basic, Total Net loss per share, basic Repayments of Long-term Debt, Total Repayments of Long-Term Debt Repayment of term loan Series B Redeemable Convertible Preferred Stock Series B Redeemable Convertible Preferred Stock [Member] Series B redeemable convertible preferred stock. Allievex Purchase Agreement Allievex Purchase Agreement [Member] Allievex purchase agreement. Total current liabilities Liabilities, Current Pre-funded warrants, expiration period Expiration Date of Pre-Funded Warrants Expiration date of pre-funded warrants. Increase (Decrease) in Accounts Receivable Accounts receivable Adjustments to reconcile net loss to net cash used in operating activities: Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity [Abstract] Number of monthly installments Number Of Monthly Installments Number of monthly installments. Restructuring and Related Cost, Number of Positions Eliminated, Period Percent Percentage of reduction in workforce Stockholders’ equity: Equity, Attributable to Parent [Abstract] Entity Small Business Entity Small Business Increase (Decrease) in Accrued Liabilities, Total Increase (Decrease) in Accrued Liabilities Accrued expenses and other current liabilities Short Term Investments Short-Term Debt [Member] Research and Development [Abstract] Retained Earnings (Accumulated Deficit), Ending Balance Retained Earnings (Accumulated Deficit), Beginning Balance Retained Earnings (Accumulated Deficit), Total Accumulated deficit Retained Earnings (Accumulated Deficit) Loss on disposal of property and equipment Loss on Disposal of Property and Equipment Loss on disposal of property and equipment Development and Regulatory Milestones Development and regulatory milestones Development and regulatory milestones Restricted Stock, Value, Shares Issued Net of Tax Withholdings Issuance of common stock related to vesting of restricted stock units, net of tax withholdings Risks and Uncertainties Risks And Uncertainties Policy [Text Block] Risks and uncertainties.. Warrants and Rights Outstanding, Measurement Input Pre-funded warrants Share-Based Payment Arrangement [Text Block] Stock-Based Compensation Expense Organization, Consolidation and Presentation of Financial Statements [Abstract] Leases [Abstract] Lessee, Lease, Description [Line Items] Amendment Flag Amendment Flag Product and Service [Domain] Money Market Funds Money Market Fund [Member] Money Market Fund Member. Proceeds from maturities of investments Proceeds from Sale, Maturity and Collection of Investments Proceeds from Sale, Maturity and Collection of Investments, Total Liabilities and Equity [Abstract] LIABILITIES, REDEEMABLE PREFERRED STOCK, AND STOCKHOLDERS' EQUITY Entity Address, Postal Zip Code Entity Address, Postal Zip Code Net cash used in operating activities Cash Provided by (Used in) Operating Activity, Including Discontinued Operation Common Stock Common Stock [Member] Long-Term Debt, Maturity, Year One 2025 (remaining 6 months) Less: interest Debt Interest Total interest under term loan. Research and Development Arrangement, Contract to Perform for Others, Type [Domain] Entity Address, Address Line One Entity Address, Address Line One Fair Value Hierarchy and NAV Fair Value Hierarchy and NAV [Axis] Clinical development milestones member. Clinical Development Milestones [Member] Clinical Development Milestones Earnings Per Share [Abstract] Debt Securities, Available-for-Sale, Unrealized Loss Position Fair value, total Fair value, total Class of Warrant or Right [Axis] Document Type Document Type Collaborative Arrangement and Arrangement Other than Collaborative Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Collaborative Arrangement and Arrangement Other than Collaborative Collaborative Arrangement and Arrangement Other than Collaborative [Domain] Entity Central Index Key Entity Central Index Key Prime Rate Prime Rate [Member] Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Excluding Exchange Rate Effect, Including Discontinued Operation Net decrease in cash, cash equivalents, and restricted cash Subsequent Event Type [Domain] Fair Value Adjustment of Warrants Change in fair value of warrant liability Change in fair value Restricted stock units, issued and outstanding Restricted Stock Units Issued And Outstanding Member Restricted Stock Units Issued And Outstanding [Member] Accrued Investment Income Receivable, Total Accrued Investment Income Receivable Accrued interest on investments Potential dilutive securities excluded from diluted net loss per share Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Balance Sheet Related Disclosures [Abstract] Common stock par value per share Common stock, par value Common Stock, Par or Stated Value Per Share Sales Milestones Sales milestones Sales milestones First Tranche Term Loan First Tranche Term Loan [Member] First tranche term loan. Increase (Decrease) in Other Operating Liabilities, Total Other liabilities Increase (Decrease) in Other Operating Liabilities Cash equivalents and investments securities, Amortized Cost Cash equivalents and available for sale securities, amortized cost Debt Securities, Available-for-Sale, Amortized Cost Amortized Cost Total cash equivalents and available-for-sale securities Available for sale, fair value Debt Securities, Available-for-Sale Available for sale securities, Fair value Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period Exercise of common stock options, Shares Debt Disclosure [Abstract] Restructuring and Related Cost, Expected Cost Restructuring and Related Cost, Expected Cost, Total Cash charges Accrued Liabilities, Current Total accrued expenses and other current liabilities Accrued expenses and other current liabilities Termination date Termination Date Termination date. Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items] Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] Current Fiscal Year End Date Current Fiscal Year End Date Debt Instrument [Table] Schedule of Long-Term Debt Instruments [Table] Document Quarterly Report Document Quarterly Report Entity Address, State or Province Entity Address, State or Province Debt Instrument, Convertible, Threshold Consecutive Trading Days Consecutive trading days Debt issuance costs Debt Issuance Costs, Gross Financial Liabilities Fair Value Disclosure Financial Liabilities Fair Value Disclosure, Total Preferred Stock, Shares Outstanding, Ending Balance Preferred Stock, Shares Outstanding, Beginning Balance Preferred stock, shares outstanding Preferred Stock, Shares Outstanding Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax Gross Unrealized Gains Shares reserved for issuance Shares reserved for future issuance Common Stock, Capital Shares Reserved for Future Issuance Class of Warrant or Right [Domain] Geographical [Axis] Kaken License Agreement Kaken License Agreement [Member] Kaken License Agreement Accrued general and administrative expenses Accrued General And Administrative Expenses Accrued general and administrative expenses. Annual interest License Agreement Interest Rate License agreement interest rate. Summary of Stock-Based Compensation Expense Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block] Stock Issued During Period, Value, Stock Options Exercised Exercise of common stock options Preferred Stock, Redemption Price Per Share Preferred stock redemption price per share Interest and Other Income Interest and other income, net Collaborative Arrangement Disclosure [Text Block] License and Purchase Agreements Subsequent Event Subsequent Event [Member] Debt Securities, Available-for-sale, Realized Gain (Loss), Excluding Other-than-temporary Impairment, Total Debt securities, available-for-sale, realized gain (loss), excluding other-than-temporary impairment Debt Securities, Available-for-Sale, Realized Gain (Loss), Excluding Other-than-temporary Impairment Other Assets, Noncurrent, Total Other assets Other Assets, Noncurrent Less: unamortized debt issuance costs Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net, Total Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net Fair Value Measurement Inputs and Valuation Techniques [Table] Measurement Input, Expected Term [Member] Expected term Antidilutive Securities Antidilutive Securities [Axis] Significant Accounting Policies Basis of Presentation and Significant Accounting Policies [Text Block] Second Tranche Term Loan Second Tranche Term Loan [Member] Second tranche term loan. Accumulated Other Comprehensive Gain/(Loss) AOCI Attributable to Parent [Member] The First Amendment First Amendment To Loan And Security Agreement [Member] First Amendment To Loan And Security Agreement [Member] Aggregate license agreement amount Aggregate License Agreement Amount Aggregate license agreement amount. Operating Leases, option to renew lease term description Lessee, Operating Lease, Option to Extend Preferred Stock, Value, Issued, Ending Balance Preferred Stock, Value, Issued, Beginning Balance Preferred Stock, Value, Issued, Total Preferred Stock, Value, Issued Preferred stock Asset Acquisition, Consideration Transferred, Contingent Consideration Contingent consideration paid Debt instrument, maturity date Debt Instrument, Maturity Date Minimum Minimum [Member] Potential milestone payments payable. Potential Additional Payment Potential Additional Payment Financial Instrument Financial Instrument [Axis] Current assets: Assets, Current [Abstract] Second amendment to loan and security agreement member. Second Amendment To Loan And Security Agreement [Member] The Second Amendment Common stock and warrant net offering costs. Common Stock and Warrant Net Offering Costs offering costs Level 3 Fair Value, Inputs, Level 3 [Member] Fair Value Non-recurring Fair Value, Nonrecurring [Member] Fair Value, Assets Measured on Recurring Basis [Table Text Block] Summary of Financial Assets and Liabilities Measured at Fair Value on Recurring Basis Current liabilities: Liabilities, Current [Abstract] Shares subject to outstanding common stock options Shares Subject To Outstanding Common Stock Options [Member] Shares subject to outstanding common stock options. Related Party Transactions [Abstract] Debt Securities, Available-for-Sale, Unrealized Loss Position, Fair Value [Table Text Block] Summary of investments in an unrealized loss position Operating leases, renew lease term Lessee, Operating Lease, Renewal Term Proceeds from Stock Plans Proceeds from issuance of common stock related to employee stock purchase plan Commitments and contingencies Commitments and Contingencies Series A Redeemable Preferred Stock [Member] Series A redeemable preferred stock. Series A Redeemable Preferred Stock Upfront payments Upfront Payments Upfront payments General and Administrative General and Administrative Expense [Member] Total operating lease liability Operating Lease, Liability Operating Lease, Liability, Total Short-term lease gross commitments Short-Term Lease Commitment, Amount Common Stock Warrants [Member] Common Stock Warrants [Member] Common Stock Warrants, issued and outstanding Long-Term Debt, Maturity, Year Two 2026 Net Income (Loss), Including Portion Attributable to Noncontrolling Interest, Total Net loss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest Weighted Average Number of Shares Outstanding, Basic, Total Weighted-average shares of common stock outstanding, basic Weighted-average shares of common stock outstanding, basic Amount of debt available under the first tranche Debt Available First Tranche Amount of debt available under the first tranche. Shares available for future issuance under 2020 Equity Incentive Plan Shares Available For Future Issuance Under Two Thousand And Twenty Equity Incentive Plan [Member] Shares available for future issuance under two thousand and twenty equity incentive plan. Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table] Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss Gross unrealized losses, twelve months or greater Gross unrealized losses, twelve months or greater Stock Issued During Period, Shares, Reverse Stock Splits Reverse stock split , shares Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures, Total Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures Stock options granted Subsequent Events Subsequent Events [Text Block] Asset Acquisition, Consideration Transferred, Transaction Cost Transaction costs Total Aggregate principal amount Long-Term Debt Related Party Transactions Disclosure [Text Block] Related Party Transactions Exercise payment Exercise Payment Exercise payment. APIC, Share-based Payment Arrangement, Increase for Cost Recognition, Total Stock-based compensation APIC, Share-Based Payment Arrangement, Increase for Cost Recognition Variable Rate Variable Rate [Domain] Balance Balance Equity, Attributable to Parent Total stockholders equity Payments to Acquire Investments, Total Purchase of investments Payments to Acquire Investments Preferred Stock, Par Value Preferred Stock, Par or Stated Value Per Share Basis of Accounting, Policy [Policy Text Block] Basis of Presentation Operating Leases, option to renew lease term Lessee, Operating Lease, Existence of Option to Extend [true false] Statement of Stockholders' Equity [Abstract] Shares subject to outstanding Standard Warrants. Shares Subject to Outstanding Standard Warrants [Member] Shares subject to outstanding common stock warrants Use of Estimates Use of Estimates, Policy [Policy Text Block] Schedule of common stock shares reserved for future issuance Schedule Of Common Stock Shares Reserved For Future Issuance Table [TextBlock] Schedule of common stock shares reserved for future issuance. Financing Receivable, Allowance for Credit Loss, Beginning Balance Financing Receivable, Allowance for Credit Loss, Ending Balance Financing Receivable, Allowance for Credit Loss Allowance for credit losses Entity Address, Address Line Two Entity Address, Address Line Two Fair Value Measurements Fair Value Disclosures [Text Block] Operating lease termination date Operating Lease Termination Month And Year Operatingleaseterminationmonthandyear Schedule of Accrued Liabilities [Table Text Block] Debt Instrument, Name Debt Instrument, Name [Domain] Other current assets Other Assets, Current Increase (Decrease) in Other Operating Assets, Total Other assets Increase (Decrease) in Other Operating Assets Interest Expense, Total Interest expense Interest Expense, Operating and Nonoperating Interest expense Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Entity Entity [Domain] Short-term lease extended term Lessee Operating Lease Extended Term Of Contract Lessee operating lease extended term of contract. Restricted Stock, Shares Issued Net of Shares for Tax Withholdings Issuance of common stock related to vesting of restricted stock units, net of tax withholdings, shares Entity Address, City or Town Entity Address, City or Town Number of Reportable Segments Number of reportable segment Emerging Growth Company Status Emerging Growth Company Policy Policy [Text Block] Emerging growth company policy. Security Exchange Name Security Exchange Name Debt Instrument, Variable Interest Rate, Type [Extensible Enumeration] Term Loan, gross Long-Term Debt, Gross Carrying value of the Term Loan Counterparty Name [Axis] RSUs granted Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Granted Measurement Input Type [Domain] Antidilutive Securities, Name Antidilutive Securities, Name [Domain] Warrant Liability Warrant liability. Warrant liability Fair value as of June 30, 2025 Fair value as of December 31, 2024 Debt instrument prepayment fee percentage Debt Instrument Prepayment Fee Percentage Debt instrument prepayment fee percentage. Cash, cash equivalents, and restricted cash at end of period Cash, cash equivalents, and restricted cash at beginning of period Total cash, cash equivalents and restricted cash Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Table] Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table] Statistical Measurement Statistical Measurement [Domain] End of term payment, percentage End Of Term Payment Percentage End of term payment, percentage. Debt Instrument Interest Rate Percentage Scenario One Debt Instrument Interest Rate Percentage Scenario One Floating interest scenario one Warrants exercise price Class of Warrant or Right, Exercise Price of Warrants or Rights Total current assets Assets, Current Lease Liability Current Lease liabilities, current portion Present value of lessee's discounted obligation for lease payments from leases, classified as current. Stock-based compensation expense Total stock-based compensation expense Share-Based Payment Arrangement, Expense Document Period End Date Document Period End Date Debt Instrument Interest Rate Percentage Scenario Two Debt Instrument Interest Rate Percentage Scenario Two Floating interest scenario two Fair Value Hierarchy and NAV Fair Value Hierarchy and NAV [Domain] Accrued research and development expenses Accrued Research And Development Expenses Accrued research and development expenses. Statement of Financial Position [Abstract] RSU Restricted Stock Units (RSUs) [Member] Short-Term Investments , Corporate Bond Securities Short-Term Debt , Corporate Bond Securities [Member] Short-Term Debt , Corporate Bond Securities Member. Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Table] Antidilutive Security, Excluded EPS Calculation [Table] Vesting [Axis] Reconciliation of cash, cash equivalents, and restricted cash Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation [Abstract] Class of Stock Class of Stock [Axis] Debt Securities, Available-for-sale, Realized Gain (Loss), Total Debt securities, available-for-sale, realized gain (loss) Debt Securities, Available-for-Sale, Realized Gain (Loss) Total liabilities Liabilities Financial Instruments Financial Instruments [Domain] Measurement Input, Exercise Price [Member] Exercise price Operating lease commencement date Operating Lease Commencement Month And Year Operating lease commencement date. Increase (Decrease) in Deferred Revenue Deferred revenue South San Francisco, California. South San Francisco, California [Member] South San Francisco, California Standard Warrants Standard Warrants [Member] Standard warrants. Standard Warrants, issued and outstanding Series A Redeemable Convertible Preferred Stock Series A Redeemable Convertible Preferred Stock Series A Redeemable Convertible Preferred Stock [Member] Series A redeemable convertible preferred stock. Variable Rate Variable Rate [Axis] Shares subject to outstanding RSUs Shares Subject to Outstanding Restricted Stock Units [Member] Shares subject to outstanding restricted stock units. Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss Gross unrealized losses, less than twelve months Gross unrealized losses, less than twelve months Weighted Average Number of Shares Outstanding, Diluted, Total Weighted-average shares of common stock outstanding, diluted Weighted-average shares of common stock outstanding, diluted Entity File Number Entity File Number Cover [Abstract] Measurement Input Type [Axis] Consideration assumed as accrued expenses and other current liabilities Business Combination, Recognized Liability Assumed, Other Liability, Current Balance Sheet Components Supplemental Balance Sheet Disclosures [Text Block] Number of operating segment Number of Operating Segments Sale of Stock Sale of Stock [Domain] General and Administrative Expense, Total General and administrative General and Administrative Expense Regulatory Milestone Regulatory milestone. Regulatory milestone Subsequent Event [Table] Grant Date Fair Value Grant date fair value. Grant date fair value Restricted and performance stock units, issued and outstanding Restricted and Performance Stock Units, Issued and Outstanding [Member] Restricted and performance stock units, issued and outstanding. Share-Based Compensation Arrangement by Share-Based Payment Award, Option, Nonvested, Weighted Average Exercise Price, Beginning Balance Share-Based Compensation Arrangement by Share-Based Payment Award, Option, Nonvested, Weighted Average Exercise Price, Ending Balance Share-Based Compensation Arrangement by Share-Based Payment Award, Option, Nonvested, Weighted Average Exercise Price Weighted Average Grant Date Fair Value Per Share Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Net exercised of common stock Stock Issued During Period, Shares, Conversion of Convertible Securities Amount of total debt available Debt Total Available Amount of total debt available. Term Loan Term Loan [Member] Term loan. Research and Development Arrangement, Contract to Perform for Others, Costs Incurred, Gross Research and development arrangement, costs incurred Us government treasury security. Us government Treasury Security [Member] US government Treasury Securities Balance, Shares Common stock, shares outstanding Balance, Shares Common Stock, Shares, Outstanding Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] Document Transition Report Document Transition Report Total operating expenses Operating Expenses Research and Development Expense, Total Research and development Research and Development Expense Leases Lessee, Operating Leases [Text Block] Statement of Cash Flows [Abstract] Aggregate net acquisition cost Payments to Acquire Businesses, Net of Cash Acquired Payments to Acquire Businesses, Net of Cash Acquired, Total Capital Structure Equity [Text Block] Net Loss Per Share Earnings Per Share [Text Block] Schedule of Accrued Expenses and Other Current Liabilities Schedule of Accrued Expenses and Other Current Liabilities [Table Text Block] Schedule of accrued expenses and other current liabilities. Measurement Input, Expected Dividend Rate [Member] Expected dividend rate Net Income (Loss) Net loss and comprehensive loss Cash and Cash Equivalents Cash and Cash Equivalent [Member] Cash and Cash Equivalent Member. Operating leases, lease expense Operating Lease, Cost Warrants and Rights Outstanding, Term Pre-funded warrants, Term Net Cash Provided by (Used in) Operating Activities, Continuing Operations, Total Cash in operations Cash Provided by (Used in) Operating Activity, Continuing Operation Cash paid for amounts included in measurement of lease liabilities Operating Lease, Payments ASSETS Assets [Abstract] Prepaid expenses and other current assets Increase (Decrease) in Prepaid Expense and Other Assets Document Fiscal Year Focus Document Fiscal Year Focus Lilly license agreement member. Lilly License Agreement [Member] Lilly License Agreement Cash flows from investing activities Cash Provided by (Used in) Investing Activity, Including Discontinued Operation [Abstract] Accounts Payable, Current, Total Accounts payable Accounts Payable, Current Land Subject to Ground Leases Area of office space Research and Development Research and Development Expense [Member] Proceeds from Stock Options Exercised Proceeds from exercise of common stock options Fair Value Disclosures [Abstract] Commitments and Contingencies Disclosure [Abstract] Pre-Funded Warrants [Member] Pre-Funded Warrants [Member] Pre Funded Warrants Debt Instrument Debt Instrument [Axis] Share-Based Payment Arrangement [Abstract] Assets, Fair Value Disclosure Assets, Fair Value Disclosure, Total Sale of Stock [Axis] Sale of Stock Debt Instrument, Fair Value Disclosure, Total Estimated fair value of term loan Debt Instrument, Fair Value Disclosure Revenues, Total Revenues Collaboration revenue Net cash provided by investing activities Cash Provided by (Used in) Investing Activity, Including Discontinued Operation Title of 12(b) Security Title of 12(b) Security Income Taxes Income Tax Disclosure [Text Block] Debt Securities, Available-for-Sale, Allowance for Credit Loss, Total Debt Securities, Available-for-Sale, Allowance for Credit Loss, Beginning Balance Debt Securities, Available-for-Sale, Allowance for Credit Loss, Ending Balance Debt Securities, Available-for-Sale, Allowance for Credit Loss Allowance for credit losses Other Liabilities, Noncurrent, Total Other liabilities Other Liabilities, Noncurrent Legal Entity Legal Entity [Axis] Changes in operating assets and liabilities: Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity, Increase (Decrease) in Operating Capital [Abstract] Income Tax Disclosure [Abstract] Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Table] Fair Value, Recurring and Nonrecurring [Table] HBM Alpha Therapeutics, Inc HBM Alpha Therapeutics, Inc. [Member] HBM Alpha Therapeutics, Inc. [Member] Additional Paid-In Capital Additional Paid-in Capital [Member] Measurement Frequency Measurement Frequency [Domain] Income Statement Location Statement of Income Location, Balance [Axis] Trading Symbol Trading Symbol Related Party Transaction [Table] Subsequent Event Type [Axis] Twist License Agreement [Member] Twist License Agreement [Member] Twist License Agreement Cash flows from financing activities Cash Provided by (Used in) Financing Activity, Including Discontinued Operation [Abstract] Fair Value Recurring Fair Value, Recurring [Member] Entity Ex Transition Period Entity Ex Transition Period Estimated Shares Issuable Under Employee Stock Purchase Plan [Member] Estimated shares issuable under the employee stock purchase plan. Estimated shares issuable under the 2020 Employee Stock Purchase Plan Fair Value Measurement Inputs and Valuation Techniques [Line Items] Equity Components Equity Components [Axis] Equity Component Equity Component [Domain] Incurred operating expenses Incurred Operating Expenses Incurred operating expenses. ESPP issued Issuance of common stock related to employee stock purchase plan, Shares Stock Issued During Period, Shares, Employee Stock Purchase Plans Depreciation and amortization Depreciation, Depletion and Amortization, Nonproduction Depreciation, Depletion and Amortization, Nonproduction, Total Weighted-average remaining contractual term maturities available for sale Weighted Average Remaining Contractual Term Maturities Available For Sale Weighted-average remaining contractual term maturities available for sale. Common stockholders voting rights Common Stock, Voting Rights Maximum Maximum [Member] Liabilities fair value Liabilities, Fair Value Disclosure, Total Liabilities, Fair Value Disclosure Statistical Measurement Statistical Measurement [Axis] Prepaid expenses Prepaid Expense, Current, Total Prepaid Expense, Current Summary of Common Stock Reserved for Future Issuance Common Stock Capital Shares Reserved For Future Issuance Table [Text Block] Common stock capital shares reserved for future issuance. Common Stock, Value, Issued, Ending Balance Common Stock, Value, Issued, Beginning Balance Common Stock, Value, Issued, Total Common Stock, Value, Issued Common stock, $0.0001 par value; 200,000,000 shares authorized as of June 30, 2025 and December 31, 2024; 563,034 shares issued and outstanding as of June 30, 2025 and December 31, 2024 Share Based Compensation Award Tranche Four [Member] Share Based Compensation Award Tranche Four [Member] Share Based Compensation Award Tranche Four The cash inflow from the issuance of common stock and warrants. Proceeds from Issuance of Common Stock and Warrants Proceeds from issuance of common stock and warrants Warrant Liability [Member] Warrant liability. Warrant liability Preferred stock, shares authorized Preferred Stock, Shares Authorized During Liquidation Regarding Distribution To Stockholders During liquidation regarding distribution to stockholders During liquidation regarding distributed to stockholders. Tax withholding payments on restricted stock units Tax withholding payments on restricted stock units Payment, Tax Withholding, Share-Based Payment Arrangement Debt Securities, Available-for-Sale, Unrealized Loss Position, Accumulated Loss, Total Debt Securities, Available-for-Sale, Unrealized Loss Position, Accumulated Loss Gross unrealized losses, total Related Party Transaction [Line Items] Employee Stock [Member] Shares available for future issuance under 2020 Employee Stock Purchase Plan Entity Registrant Name Entity Registrant Name Term Loan Debt Disclosure [Text Block] Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax Gross Unrealized Losses Payments to Acquire in Process Research and Development Payments to acquire in process research and development MPSIIIB [Member] MPSIIIB [Member] MPSIIIB Subsequent Events [Abstract] Measurement Frequency Measurement Frequency [Axis] Share Based Compensation Arrangement By Share Based Payment Award [Line Items] Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Fair Value Measurement Inputs and Valuation Techniques [Table Text Block] Schedule of Pre-funded Warrants Measured Using Black-Scholes Option Pricing Model Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Concentration of Credit Risk Concentration Risk, Credit Risk, Policy [Policy Text Block] Total assets Assets Income Statement [Abstract] Debt instrument, extended term Debt Instrument Extended Term Debt instrument, extended term. Cash equivalents and short term investments due term Cash Equivalents And Short Term Investments Due Term Cash equivalents and short term investments due term. Legal fees Legal Fees Silicon Valley Bank Silicon Valley Bank [Member] Silicon valley bank. Net loss per share, diluted Earnings Per Share, Diluted, Total Net loss per share, diluted Dividends, Common Stock, Total Common stock dividends declared Dividends, Common Stock City Area Code City Area Code Business Combination, Consideration Transferred, Liabilities Incurred Consideration assumed as certain liabilities Lease Right of Use Asset Right-of-use assets Amount of lessee's right to use underlying asset under leases. Short term lease terminated Lessee Operating Lease Termination Date Lessee operating lease termination date. Counterparty Name [Domain] Percentage of issued pre-funded warrants Percentage of Issued Pre-Funded Warrants Percentage of issued pre-funded warrants. Amount of debt available under the second tranche Debt Available Second Tranche Amount of debt available under the second tranche. Issuance of common stock related to employee stock purchase plan Stock Issued During Period, Value, Employee Stock Purchase Plan Organization And Principal Activities [Line Items] Organization And Principal Activities [Line Items] Organization and principal activities. Weighted-average remaining lease term for operating leases Operating Lease, Weighted Average Remaining Lease Term Loss from operations Loss from operations Operating Income (Loss) Loss from operations Impairment loss on investments available for sale securities. Impairment loss on investments Available for Sale securities Debt securities, available-for-sale, realized gain (loss), excluding other-than-temporary impairment Accrued Final Payment on Term Loan Accrued final payment on term loan. Accrued final payment on term loan Accumulated Deficit Retained Earnings [Member] Share-based Payment Arrangement, Noncash Expense, Total Stock-based compensation expense Share-Based Payment Arrangement, Noncash Expense Measurement Input, Price Volatility [Member] Expected stock price volatility Compensation Expense, Excluding Cost of Good and Service Sold Stock-based compensation expense Payments of Stock Issuance Costs Payment of offering costs Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Less than 12 Months Fair value, less than twelve months weighted-average discount rate Operating Lease, Weighted Average Discount Rate, Percent Operating Lease, Liability, Noncurrent Lease liabilities, net of current portion Level 1 Fair Value, Inputs, Level 1 [Member] Class Of Stock [Line Items] Class of Stock [Line Items] Cash Provided by (Used in) Financing Activity, Including Discontinued Operation Net cash used in financing activities Unamortized debt discount and issuance costs Unamortized Debt Issuance Expense Investments Investments, Fair Value Disclosure Investments, Fair Value Disclosure, Total Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block] Schedule of Aggregate Fair Value of Warrant Liability Business Combination, Recognized Asset Acquired, Receivable, Current Estimated receivable Schedule of Potentially Dilutive Securities not Included in Calculation of Diluted Per Share Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] Securities Purchase Agreement [Member] Securities Purchase Agreement [Member] Securities Purchase Agreement Corporate Debt Securities [Member] Corporate Bonds Entity Interactive Data Current Entity Interactive Data Current Research and Development, Contract to Perform for Others [Table] Income Statement Location Statement of Income Location, Balance [Domain] Cash flows from operating activities Cash Provided by (Used in) Operating Activity, Including Discontinued Operation [Abstract] Net accretion of discount on available-for-sale securities Accretion (Amortization) of Discounts and Premiums, Investments Additional aggregate license agreement amount Additional Aggregate License Agreement Amount Additional aggregate license agreement amount. Line of Credit Facility, Current Borrowing Capacity Commitments Entity Tax Identification Number Entity Tax Identification Number Share Price Preferred Stock, Share price Organization and Principal Activities Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] End of term payment, amount End Of Term Payment Amount End of term payment, amount. Local Phone Number Local Phone Number Short-term lease expense Short-Term Lease, Cost Accounting Policies [Abstract] Numerator: Net Income (Loss) Attributable to Parent [Abstract] PotentialAdditionalCashReceipt Potential Additional Cash Receipt Potential additional cash receipt. Class of Stock Class of Stock [Domain] Cash, cash equivalents, and short-term investments Cash, Cash Equivalents, and Short-Term Investments Cash, Cash Equivalents, and Short-Term Investments, Total Schedule Of Stock By Class [Table] Stock, Class of Stock [Table] Entity Emerging Growth Company Entity Emerging Growth Company